✦ LIBER ✦

Response to infliximab in fistulizing Crohn’s disease is independent of baseline number of draining fistulas

✍ Scribed by Bruce E. Sands; Nicole A. Thorne; Paul A. Marsters; Marion A. Blank

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Type of Fistula Determines Response to I

✍ Parsi, Mansour A.; Lashner, Bret A.; Achkar, Jean-Paul; Connor, Jason T.; Brzezi 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 84 KB

Type of fistula determines-response to i

✍ Parsi, Mansour A.; Lashner, Bret A.; Achkar, Jean-Paul; Thomas, Nicole; Connor, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 221 KB

Infliximab therapy for Crohn's disease f

✍ Toy, Lisa S.; Marion, James F.; Scherl, Ellen J.; Chapman, Mark L.; Bodian, Caro 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 185 KB

Treatment with infliximab in patients wi

✍ Luna, M.; Gonzalez-Lara, V.; Garcia-Paredes, J.; Abreu, L.; Lopez-Sanroman, A.; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 221 KB

Prediction of response to infliximab in

✍ R. Chaudhary; S. Ghosh 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Infliximab is more efficacious for treat

✍ Parsi, Mansour A.; Achkar, Jean-Paul; Lashner, Bret A.; Brzezinski, Aaron 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 185 KB